Merck & Co., Inc., MRK is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in USA, Merck & Co., Inc., MRK has a market cap of 172969.11. Since its IPO date on the 1/2/1970, Merck & Co., Inc., MRK performance year to date is 19.88%. Today Merck & Co., Inc., MRK has gained -1.47%, with a current price of 61.81.
Ownership of the company is 0.04% for insider ownership while institutional ownership is 75.00%. The management of the company have seen the company have a payout ratio of 99.50%. Return of assets are at 5.20%, with return on investment at 6.40%.
In terms of debt levels and profit levels, Merck & Co., Inc., MRK is seeing a long-term debt/equity of 0.55. While Total debt/equity is 0.56. With a profit margin of 13.00%, this is combined with a gross margin of 63.20%, and operating margin of 18.10%. Merck & Co., Inc. ability to meet debt levels, with a current ratio of 1.9, while the quick ratio is 1.5.
For the last year Merck & Co., Inc., MRK has seen a EPS growth of -61.60%. A performance for the year of 22.03%. The 52-week high is -3.42%, and the 52-week low is 31.84%. The average volume for Merck & Co., Inc., MRK is 10173500.
With a target price of 65.47, can Merck & Co., Inc., MRK reach this target? Looking at the value indicators of Merck & Co., Inc., MRK. Merck & Co., Inc. has a P/E of 33.85 and a forward P/E of 16.06. Perhaps the more useful indicator than P/E, is PEG which has a value of 5.35. Merck & Co., Inc. also has a P/S and a P/B of 4.39 and 3.95 respectively. For P/cash, Merck & Co., Inc. has a value of 14.62, while it is 36.43 for P/free cash flow.
At the current price of 61.81, Merck & Co., Inc. has a dividend yield of 2.98%. We see a return on equity of 11.60%.
Looking more long-term Merck & Co., Inc., is projected to get an EPS growth for the next five years of 6.33%. In the short-term an EPS growth of 2.72% in the next year is forecasted. This is after a EPS growth of -61.60% for this year and for the last five years a 41.50% growth has been seen.